Betty Soliven to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Betty Soliven has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.007
-
Phase I study of suramin administered by intermittent infusion without adaptive control to cancer patients: update of two expanded dose levels near the maximally tolerated dose. J Clin Oncol. 1996 Sep; 14(9):2622-3.
Score: 0.007